Green Cross LabCell Rises 5.73% Amid Cord Blood Theme Uptrend
On the 13th, the umbilical cord blood theme rose 3.48% compared to the previous day, showing strength, while Green Cross LabCell, attracting attention as a related stock, surged 5.73% compared to the previous day. Green Cross LabCell is known as a cell therapy research and development company.
[Graph] Major stock price changes in the umbilical cord blood theme
According to the analysis by Thinkpool Robo Algorithm RASSI, Green Cross LabCell's quant financial score is 20.17 points, with higher growth and stability scores than the average of other umbilical cord blood-related stocks, but its quant financial ranking was only 4th out of 7 stocks. On the other hand, CHA Biotech ranked 1st in quant financial ranking with higher growth, stability, and profitability scores compared to other stocks.
[Table] Top stocks by financial score within the theme
※ The quant financial score is the result of the Robo Algorithm analyzing each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.
※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist Thinkpool.
Hot Picks Today
"Suspicious Timing?"...Trump Traded Stocks After Praising Wartime Capabilities
- "Even If I Lose My Investment, the Government Will Cover It"... The Fund Attracting Retail Investors' Attention [Weekend Money]
- There Is a Distinct Age When Physical Abilities Decline Rapidly... From What Age Do Strength and Endurance Drop?
- "I Went to 10 Convenience Stores and Still Couldn't Buy It": The Bread Sensation That Sold 100 Million Units Already [The Way We Shop Now]
- "Contact Me First If Houses Are Built": Wealthy Clients Eyeing... Will Ultra-High-End Residences Worth 20 Billion Won Be Developed? [Real Estate AtoZ]
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
